Nephros (NEPH) Insider Trading & Ownership $1.57 -0.03 (-1.63%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Nephros (NASDAQ:NEPH) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.10%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$123,160.00Number OfInsiders Selling(Last 12 Months)0 Get NEPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Nephros stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NEPH Insider Buying and Selling by Quarter Nephros Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/30/2024Arthur H AmronDirectorBuy3,000$2.24$6,720.00 5/28/2024Arthur H AmronDirectorBuy2,000$2.22$4,440.00 5/16/2024Robert R Jr. BanksCEOBuy50,000$2.24$112,000.00 (Data available from 1/1/2013 forward) NEPH Insider Trading Activity - Frequently Asked Questions Who is on Nephros's Insider Roster? The list of insiders at Nephros includes Arthur H Amron, and Robert R Jr. Banks. Learn more on insiders at NEPH. What percentage of Nephros stock is owned by insiders? 4.10% of Nephros stock is owned by insiders. Learn more on NEPH's insider holdings. Which Nephros insiders have been buying company stock? The following insiders have purchased NEPH shares in the last 24 months: Arthur H Amron ($11,160.00), and Robert R Jr. Banks ($151,748.50). How much insider buying is happening at Nephros? Insiders have purchased a total of 73,099 NEPH shares in the last 24 months for a total of $162,908.50 bought. Nephros Key ExecutivesMr. Robert Banks (Age 49)President, CEO & Director Compensation: $474.04kMs. Judy F. Krandel C.F.A. (Age 59)Chief Financial Officer Compensation: $147.01kMr. Alfred VargasDirector of OperationsBrianne McGuireDirector of Brand, Marketing & Business DevelopmentVashone R. ThomasVice President of Quality, Regulatory, & Human ResourcesMr. Daron G. Evans M.B.A. (Age 50)M.S., Chief Executive Officer of Specialty Renal Products, Inc Compensation: $300.18kMr. Greg LucasPresident of Aether Water SystemsMs. Judy MazziniController More Insider Trading Tools from MarketBeat Related Companies APT Insider Ownership CTSO Insider Ownership APYX Insider Ownership ICAD Insider Ownership INO Insider Ownership LUCD Insider Ownership MODD Insider Ownership OM Insider Ownership DXR Insider Ownership MDAI Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:NEPH) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nephros, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nephros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEPH Stock Alerts